Model systems for examining effects of leukemia associated oncogenes in primary human CD34+ cells via retroviral transduction

Methods in Molecular Biology

Volumn 538, Issue , 2009, Pages 263-285

  Wunderlich, Mark ^a   Mulloy, James C ^a  

^a CCHMC   (United States)

Author keywords

CD34; Differentiation; Human HSPC; Leukemia fusion genes; NOD SCID; Retroviral transduction; Xenograft

Indexed keywords

BETA 2 MICROGLOBULIN; CD34 ANTIGEN;

ANIMAL; ARTICLE; DISEASE MODEL; FETUS BLOOD; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; LEUKEMIA; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; ONCOGENE; PHYSIOLOGY; RETROVIRUS;

ANIMALS; ANTIGENS, CD34; BETA 2-MICROGLOBULIN; DISEASE MODELS, ANIMAL; FETAL BLOOD; GENETIC VECTORS; HUMANS; LEUKEMIA; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; ONCOGENES; RETROVIRIDAE; TRANSDUCTION, GENETIC;

EID: 65649130468     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-418-6_13     Document Type: Article

References (32)

1. Sharpless NE, Depinho RA. (2006). The mighty mouse: Genetically engineered mouse models in cancer drug development. Nat Rev Drug Discov; 5 (9): 741-54. (Pubitemid 44323701)
2. Rangarajan A, Weinberg RA. (2003). Opinion: Comparative biology of mouse versus human cells: Modelling human cancer in mice. Nat Rev Cancer; 3 (12): 952-9. (Pubitemid 37500180)
3. Rangarajan A, Hong SJ, Gifford A, Weinberg RA. (2004). Species- and cell type-specific requirements for cellular transformation. Cancer Cell; 6 (2): 171-83. (Pubitemid 39485689)
4. Drayton S, Peters G. (2002). Immortalisa- tion and transformation revisited. Curr Opin Genet Dev; 12 (1): 98-104.
5. Smogorzewska A, de Lange T. (2002). Dif- ferent telomere damage signaling pathways in human and mouse cells. Embo J; 21 (16): 4338-48.
6. Hamad NM, Elconin JH, Karnoub AE, et al. (2002). Distinct requirements for Ras onco-genesis in human versus mouse cells. Genes Dev; 16 (16): 2045-57.
7. Lim KH, Baines AT, Fiordalisi JJ, et al. (2005). Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell; 7 (6): 533-45. (Pubitemid 40799247)
8. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. (1999). Creation of human tumour cells with defined genetic elements. Nature; 400 (6743): 464-8. (Pubitemid 29361801)
9. Hahn WC, Weinberg RA. (2002). Rules for making human tumor cells. N Engl J Med; 347 (20): 1593-603. (Pubitemid 35315841)
10. Pereira DS, Dorrell C, Ito CY, et al. (1998). Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc Natl Acad Sci U S A; 95 (14): 8239-44. (Pubitemid 28326097)
11. Grignani F, Valtieri M, Gabbianelli M, et al. (2000). PML/RAR alpha fusion protein expression in normal human hemat-opoietic progenitors dictates myeloid commitment and the promyelocytic pheno-type. Blood; 96 (4): 1531-7. (Pubitemid 30658487)
12. Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA, Nimer SD. (2002). The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood; 99 (1): 15-23.
13. Buske C, Feuring-Buske M, Antonchuk J, et al. (2001). Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. Blood; 97 (8): 2286-92. (Pubitemid 32291473)
14. Daga A, Podesta M, Capra MC, Piaggio G, Frassoni F, Corte G. (2000). The retro-viral transduction of HOXC4 into human CD34(+) cells induces an in vitro expansion of clonogenic and early progenitors. Exp Hema-tol; 28 (5): 569-74. (Pubitemid 30254458)
15. Barabe F, Kennedy JA, Hope KJ, Dick JE. (2007). Modeling the initiation and progression of human acute leukemia in mice. Science; 316 (5824): 600-4. (Pubitemid 46683146)
16. Bowie MB, Kent DG, Dykstra B, et al. (2007). Identification of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties. Proc Natl Acad Sci U S A; 104 (14): 5878-82. (Pubitemid 47175627)
17. Holyoake TL, Nicolini FE, Eaves CJ. (1999). Functional differences between transplant-able human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp Hematol; 27 (9): 1418-27. (Pubitemid 29409461)
18. Kelly PF, Carrington J, Nathwani A, Vanin EF. (2001). RD114-pseudotyped oncoretroviral vectors. Biological and physical properties. Ann N Y Acad Sci; 938: 262-76; discussion 76-7.
19. Kelly PF, Vandergriff J, Nathwani A, Nienhuis AW, Vanin EF. (2000). Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood; 96 (4): 1206-14. (Pubitemid 30658445)
20. Hanawa H, Kelly PF, Nathwani AC, et al. ( 2002). Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther; 5 (3): 242-51. (Pubitemid 34211219)
21. Wunderlich M, Krejci O, Wei J, Mulloy JC. (2006). Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomono-cytic phenotype with greatly enhanced prolif-erative ability. Blood; 108 (5): 1690-7. (Pubitemid 44316139)
22. Mulloy JC, Cammenga J, Berguido FJ, et al. (2003). Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element. Blood; 102 (13): 4369-76. (Pubitemid 37494097)
23. Itoh K, Tezuka H, Sakoda H, et al. (1989). Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow. Exp Hematol; 17 (2): 145-53. (Pubitemid 19056039)
24. Ito M, Hiramatsu H, Kobayashi K, et al. (2002). NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood; 100 (9): 3175-82. (Pubitemid 35217065)
25. Nicolini FE, Cashman JD, Hogge DE, Hum- phries RK, Eaves CJ. (2004). NOD/SCID mice engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize engrafted human progenitors and compromise human stem cell regeneration. Leukemia; 18 (2): 341-7. (Pubitemid 38240052)
26. Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE. (2003). Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors. Leukemia; 17 (4): 760-3. (Pubitemid 36519373)
27. Haas DL, Case SS, Crooks GM, Kohn DB. (2000). Critical factors influencing stable trans-duction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther; 2 (1): 71-80.
28. Sandrin V, Boson B, Salmon P, et al. (2002). Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood; 100 (3): 823-32. (Pubitemid 34832607)
29. Wang J, Kimura T, Asada R, et al. (2003). SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood; 101 (8): 2924-31. (Pubitemid 36857976)
30. Yahata T, Ando K, Sato T, et al. ( 2003). A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood; 101 (8): 2905-13. (Pubitemid 36857974)
31. Wei J, Wunderlich M, Fox C, Alvarez S, Cigu-dosa JC, Wilhelm JE, Zheng Y, Cancelas JA, Gu Y, Jansen M, DiMartino JF and Mulloy, JC (2008) Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia. Cancer Cell; 13 (6): 483-495. (Pubitemid 351763903)
32. Mulloy JC, Wunderlich M, Zheng Y, Wei J. (2008) Transforming Human Blood Stem and Progenitor Cells: A New Way Forward in Leukemia Modeling. Cell Cycle; 7 (21): 57-52.